We are live on ! Find out more
IH

iHuman

7 hedge funds and large institutions have $8.02M invested in iHuman in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

17% more funds holding

Funds holding: 67 (+1)

8% more capital invested

Capital invested by funds: $7.46M → $8.02M (+$568K)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.11% less ownership

Funds ownership: 2.88%2.77% (-0.11%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.12%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
2
Increased
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
APA
1
Arisaig Partners (Asia)
Singapore
$6.08M
Morgan Stanley
2
Morgan Stanley
New York
$1.54M -$417K -158,152 -20%
JP Morgan Chase
3
JP Morgan Chase
New York
$340K
State Street
4
State Street
Massachusetts
$40K -$348 -132 -0.8%
Bank of America
5
Bank of America
North Carolina
$14K -$5.04K -1,914 -24%
UBS Group
6
UBS Group
Switzerland
$7K +$7.76K +2,947 New
Millennium Management
7
Millennium Management
New York
-$24K -11,226 Closed
BlackRock
8
BlackRock
New York
+$461 +175 New

IH Hedge Fund Activity: Q2 2022 in Review

7 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in iHuman (IH) for Q2 2022, worth a combined $8.02M — up 7.6% from $7.46M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new IH positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $7.76K. The largest seller was Morgan Stanley, cutting an estimated $417K.

  • 7 institutional investors held iHuman (IH) as of Q2 2022, up from 6 in Q1 2022.
  • Funds reported $8.02M of iHuman stock for Q2 2022, up 7.6% quarter-over-quarter.
  • 2 funds opened new iHuman positions in Q2 2022 and 1 closed out, a net change of +1 holder.
  • The largest iHuman buyer in Q2 2022 was UBS Group, an estimated $7.76K added.
  • The largest iHuman seller in Q2 2022 was Morgan Stanley, an estimated $417K sold.

Based on aggregated 13F filings for Q2 2022.